Understanding the structure/activity relationships of the iron regulatory peptide hepcidin (#39)

11:00 AM

Richard J Clark

A novel non-animal collagen-like protein functionalized using expressed protein ligation (#40)

11:07 AM

Friederike Fehr

Post-antibody medicines “MicroAntibodies”: Generation of molecular-targeting peptides by directed evolution (#41)

11:14 AM

Ikuo Fujii

Exploring bioactive peptides as pharmacological tools for oxytocin and vasopressin ligand design (#42)

11:21 AM

Christian W Gruber

Total Chemical Synthesis of the antimicrobial peptides Snakin 1 and 2 (#43)

11:28 AM

Paul WR Harris

Downsizing proteins into short water-stable alpha helices that maintain biological properties (#44)

11:35 AM

Timothy A Hill

In vitro selected cyclic peptides for the cocrystallization and inhibition of a transmembrane multidrug transporter (#45)

11:42 AM

Christopher J Hipolito

Proline-rich antimicrobial peptides of the apidaecin and oncocin family – in vivo therapeutic potential and pharmacokinetics in mice (#46)

11:49 AM

Daniel Knappe

De Novo Design Natural Xanthone Derivatives Based Peptidomimics to Mimick the Topology of Cationic Antimicrobial Peptides with Potentials for Topical Application (#47)

11:56 AM

Shouping Liu

Macrocyclisation of Peptides by Novel Stable Selenoether Bridges (#48)

12:03 PM

Aline Dantas de Araujo

Natural Sources for Oxytocin and Vasopressin Ligand Design (#49)

12:10 PM

Markus Muttenthaler

In Silico platform for predicting and designing therapeutic peptides for drug delivery (#50)

12:17 PM

Ankur Gautam